105 related articles for article (PubMed ID: 15773560)
1. [Molecular genetic analysis of thimidine kinase from herpes simplex virus type 1].
Gus'kova AA; Zagurnyĭ AV; Skoblov MIu; Baranova AV; Andronova VL; Iankovskiĭ NK; Galegov GA; Skoblov IuS
Mol Biol (Mosk); 2005; 39(1):155-8. PubMed ID: 15773560
[No Abstract] [Full Text] [Related]
2. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
3. Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study.
Frobert E; Ooka T; Cortay JC; Lina B; Thouvenot D; Morfin F
Antiviral Res; 2007 Feb; 73(2):147-50. PubMed ID: 16970995
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
[TBL] [Abstract][Full Text] [Related]
5. Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.
Sergerie Y; Boivin G
Antimicrob Agents Chemother; 2006 Nov; 50(11):3889-92. PubMed ID: 16982796
[TBL] [Abstract][Full Text] [Related]
6. Emergence of resistance to carbocyclic oxetanocin G in herpes simplex virus type 1 and genetic analysis of resistant mutants.
Hu N; Shiota H
Acta Pharmacol Sin; 2004 Jul; 25(7):921-6. PubMed ID: 15210066
[TBL] [Abstract][Full Text] [Related]
7. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
8. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients.
Morfin F; Souillet G; Bilger K; Ooka T; Aymard M; Thouvenot D
J Infect Dis; 2000 Jul; 182(1):290-3. PubMed ID: 10882609
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses.
Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P
J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177
[TBL] [Abstract][Full Text] [Related]
10. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
11. Antiherpetic properties of acyclovir 5'-hydrogenphosphonate and the mutation analysis of herpes virus resistant strains.
Gus'kova AA; Skoblov MY; Korovina AN; Yasko MV; Karpenko IL; Kukhanova MK; Andronova VL; Galegov GA; Skoblov YS
Chem Biol Drug Des; 2009 Oct; 74(4):382-9. PubMed ID: 19691467
[TBL] [Abstract][Full Text] [Related]
12. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir.
Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
Dokl Biochem Biophys; 2015; 460():42-6. PubMed ID: 25772989
[No Abstract] [Full Text] [Related]
13. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
Stránská R; van Loon AM; Polman M; Beersma MF; Bredius RG; Lankester AC; Meijer E; Schuurman R
Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
[TBL] [Abstract][Full Text] [Related]
14. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and antiherpes activity of acyclovir phosphoesters].
Galegov GA; Shobukhov VM; Leont'eva NA; Ias'ko MV
Bioorg Khim; 1997 Nov; 23(11):906-9. PubMed ID: 9518431
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
18. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.
Griffiths A; Link MA; Furness CL; Coen DM
J Virol; 2006 Jul; 80(13):6568-74. PubMed ID: 16775343
[TBL] [Abstract][Full Text] [Related]
19. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
[TBL] [Abstract][Full Text] [Related]
20. Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.
Griffiths A; Chen SH; Horsburgh BC; Coen DM
J Virol; 2003 Apr; 77(8):4703-9. PubMed ID: 12663777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
